These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Results of treatment of chronically infectious patients with rifampicin in various combinations and in various models]. Górecki R, Stanek S. Gruzlica; 1974 May; 42(5):411-6. PubMed ID: 4464229 [No Abstract] [Full Text] [Related]
7. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation]. Masztalerz J. Pneumonol Pol; 1976 May; 44(1):55-60. PubMed ID: 821043 [No Abstract] [Full Text] [Related]
8. [Treatment of patients with infiltrative tuberculosis of the lungs with tuberculin in combination with ethambutol and rifadin]. Sattar IKh. Probl Tuberk; 1984 May; (5):65-6. PubMed ID: 6377303 [No Abstract] [Full Text] [Related]
9. Ethambutol in the re-treatment of multi-resistant advanced pulmonary tuberculosis (salvage cases). Roy DC, Sen PC, Bajpai BK. Indian J Chest Dis; 1974 Jul; 16(3):153-62. PubMed ID: 4422083 [No Abstract] [Full Text] [Related]
10. [Comparative characteristics of the use of rifadin and ethambutol in the complex treatment of patients with fibro-cavernous pulmonary tuberculosis]. Tarasova EF, Sagalovich VIa. Probl Tuberk; 1974 Jul; (12):26-30. PubMed ID: 4445131 [No Abstract] [Full Text] [Related]
13. [New and future drugs in pulmonary tuberculosis]. Grosset JH, Truffot-Pernot C, Lecoeur H. Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():206-10. PubMed ID: 3174565 [No Abstract] [Full Text] [Related]
14. [Late results of treatment of newly detected pulmonary tuberculosis using various combinations of basic antitubercular agents and ethambutol by the daily and intermittent method]. Zierski M, Graczyk J. Pneumonol Pol; 1977 Apr; 45(4):265-75. PubMed ID: 854459 [No Abstract] [Full Text] [Related]
19. A clinical study on controlled therapy in newly-diagnosed pulmonary tuberculosis using combinations of antituberculosis drugs by the daily continuous and intermittent methods. Arch Immunol Ther Exp (Warsz); 1976 Dec 19; 24(2):169-84. PubMed ID: 1275660 [No Abstract] [Full Text] [Related]